Astellas has provided financial sponsorship for this webinar organised and developed by the PCWHS. Astellas has had no input into the webinar agenda, speaker selection or presentations with the exception of the symposium session which is fully funded and developed by Astellas.
The PCWHS webinar 'Advances in non‑hormonal management of the menopause' took place on Tuesday, 19th May 2026 at 19:00.
The webinar explored the evolving role of non‑hormonal treatment options across different patient age groups. Using practical case studies, the session examined who benefits most from these approaches and how they can be effectively applied in clinical practice.
You can now view the Case studies across age groups: who benefits most? with Dr Sarah Gray and the Q&A session below.
There is also an accompanying top tips resource to this webinar here
Main Webinar Recording
Astellas Sponsored Session Recording
Astellas has provided financial sponsorship for this webinar organised and developed by the PCWHS. Astellas has had no input into the webinar agenda, speaker selection or presentations with the exception of the symposium session which is fully funded and developed by Astellas.
VEOZA™▼ (fezolinetant) Prescribing information can be accessed HERE.
This promotional webinar was fully funded and organised by Astellas Pharma Ltd and Astellas products are discussed. This recording is intended for UK healthcare professionals only.
Adverse events should be reported. Reporting forms and information can be found at: https://www.yellowcard.mhra.gov.uk/.
Adverse events should also be reported to Astellas Pharma Ltd on 0800 783 5018 |
|
The website link above will take you to a non-Astellas website. Astellas do not endorse or accept liability for sites controlled by third parties.